|
1
|
Miyakis S, Lockshin MD, Atsumi T, Branch
DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni
PL, et al: International consensus statement on an update of the
classification criteria for definite antiphospholipid syndrome
(APS). J Thromb Haemost. 4:295–306. 2006.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gardiner C, Hills J, Machin SJ and Cohen
H: Diagnosis of antiphospholipid syndrome in routine clinical
practice. Lupus. 22:18–25. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Galli M, Reber G, de Moerloose P and de
Groot PG: Invitation to a debate on the serological criteria that
define the antiphospholipid syndrome. J Thromb Haemost. 6:399–401.
2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tincani A, Andreoli L, Casu C, Cattaneo R
and Meroni P: Antiphospholipid antibody profile: Implications for
the evaluation and management of patients. Lupus. 19:432–435.
2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kelchtermans H, Pelkmans L, de Laat B and
Devreese KM: IgG/IgM antiphospholipid antibodies present in the
classification criteria for the antiphospholipid syndrome: A
critical review of their association with thrombosis. J Thromb
Haemost. 14:1530–1548. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tektonidou MG, Andreoli L, Limper M,
Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T,
Ferrer-Oliveras R, Hambly K, et al: EULAR recommendations for the
management of antiphospholipid syndrome in adults. Ann Rheum Dis.
78:1296–1304. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Garcia D and Erkan D: Diagnosis and
management of the antiphospholipid syndrome. N Engl J Med.
378:2010–2021. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Montagnana M, Lippi G and Danese E: An
overview of thrombophilia and associated laboratory testing.
Methods Mol Biol. 1646:113–135. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Galli M, Luciani D, Bertolini G and Barbui
T: Lupus anticoagulants are stronger risk factors for thrombosis
than anticardiolipin antibodies in the antiphospholipid syndrome: A
systematic review of the literature. Blood. 101:1827–1832.
2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chayoua W, Kelchtermans H, Moore GW,
Musiał J, Wahl D, de Laat B and Devreese KM: Identification of high
thrombotic risk triple-positive antiphospholipid syndrome patients
is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody
detection assays. J Thromb Haemost. 16:2016–2023. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hughes GR and Khamashta MA: ‘Seronegative
antiphospholipid syndrome’: An update. Lupus. 28:273–274.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chayoua W, Kelchtermans H, Gris JC, Moore
GW, Musiał J, Wahl D, de Groot PG, de Laat B and Devreese KM: The
(non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I
IgM antibodies in the antiphospholipid syndrome. J Thromb Haemost.
18:169–179. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Campello E, Spiezia L, Adamo A and Simioni
P: Thrombophilia, risk factors and prevention. Expert Rev Hematol.
12:147–158. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gavris C, Poroch V, Simion L, Baracan A,
Toader E and Pascu AM: Biochemical markers with low-grade
inflammation as predictors of thrombotic events in antiphospholipid
syndrome. Rev Chim. 68:1586–1590. 2017.
|
|
15
|
Devreese KM, Ortel TL, Pengo V and de Laat
B: Laboratory criteria for antiphospholipid syndrome: Reply. J
Thromb Haemost. 16:2117–2119. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
De Craemer AS, Musial J and Devreese KM:
Role of anti-domain 1-β2 glycoprotein I antibodies in the diagnosis
and risk stratification of antiphospholipid syndrome. J Thromb
Haemost. 14:1779–1787. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Iwaniec T, Kaczor MP, Celińska-Löwenhoff
M, Polański S and Musiał J: Clinical significance of anti-domain 1
β2-glycoprotein I antibodies in antiphospholipid syndrome. Thromb
Res. 153:90–94. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Pignatelli P, Ettorre E, Menichelli D,
Pani A, Violi F and Pastori D: Seronegative antiphospholipid
syndrome: Refining the value of ‘non-criteria’ antibodies for
diagnosis and clinical management. Haematologica. 105:562–572.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sciascia S, Baldovino S, Schreiber K,
Solfietti L, Radin M, Cuadrado MJ, Menegatti E, Erkan D and
Roccatello D: Thrombotic risk assessment in antiphospholipid
syndrome: The role of new antibody specificities and thrombin
generation assay. Clin Mol Allergy. 14(6)2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Litvinova E, Darnige L, Kirilovsky A,
Burnel Y, de Luna G and Dragon-Durey MA: Prevalence and
Significance of non-conventional antiphospholipid antibodies in
patients with clinical APS criteria. Front Immunol.
9(2971)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Otomo K, Atsumi T, Amengual O, Fujieda Y,
Kato M, Oku K, Horita T, Yasuda S and Koike T: Efficacy of the
antiphospholipid score for the diagnosis of antiphospholipid
syndrome and its predictive value for thrombotic events. Arthritis
Rheum. 64:504–512. 2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sciascia S, Sanna G, Murru V, Roccatello
D, Khamashta MA and Bertolaccini ML: GAPSS: The Global
Anti-Phospholipid Syndrome Score. Rheumatology (Oxford).
52:1397–1403. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sciascia S, Sanna G, Murru V, Roccatello
D, Khamashta MA and Bertolaccini ML: Anti-prothrombin (aPT) and
anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the
risk of thrombosis in the antiphospholipid syndrome. A systematic
review. Thromb Haemost. 111:354–364. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sciascia S, Radin M, Cecchi I,
Bertolaccini ML, Bertero MT, Rubini E, Vaccarino A, Bazzan M,
Giachino O, Baldovino S, et al: Identifying phenotypes of patients
with antiphospholipid antibodies: results from a cluster analysis
in a large cohort of patients. Rheumatology (Oxford), 2019 (Ahead
of print).
|
|
25
|
Forastiero R, Martinuzzo M, Adamczuk Y,
Varela ML, Pombo G and Carreras LO: The combination of
thrombophilic genotypes is associated with definite
antiphospholipid syndrome. Haematologica. 86:735–741.
2001.PubMed/NCBI
|
|
26
|
Pengo V: A contribution to the debate on
the laboratory criteria that define the antiphospholipid syndrome.
J Thromb Haemost. 6:1048–1049. 2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Pengo V, Ruffatti A, Legnani C, Gresele P,
Barcellona D, Erba N, Testa S, Marongiu F, Bison E, Denas G, et al:
Clinical course of high-risk patients diagnosed with
antiphospholipid syndrome. J Thromb Haemost. 8:237–242.
2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wahl D: ‘Antiphospholipids’: The more, the
worse? Blood. 131:2092–2094. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Atsumi T, Bertolaccini ML and Koike T:
Genetics of antiphospholipid syndrome. Rheum Dis Clin North Am.
27:565–572. 2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Castro-Marrero J, Balada E,
Vilardell-Tarrés M and Ordi-Ros J: Genetic risk factors of
thrombosis in the antiphospholipid syndrome. Br J Haematol.
147:289–296. 2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yonal I, Hindilerden F, Hancer VS,
Artim-Esen B, Daglar A, Akadam B, Nalcaci M and Diz-Kucukkaya R:
The impact of platelet membrane glycoprotein Ib alpha and Ia/IIa
polymorphisms on the risk of thrombosis in the antiphospholipid
syndrome. Thromb Res. 129:486–491. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Iuliano A, Galeazzi M and Sebastiani GD:
Antiphospholipid syndrome's genetic and epigenetic aspects.
Autoimmun Rev. 18(102352)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Diz-Kucukkaya R, Hancer VS, Artim-Esen B,
Pekcelen Y and Inanc M: The prevalence and clinical significance of
inherited thrombophilic risk factors in patients with
antiphospholipid syndrome. J Thromb Thrombolysis. 29:303–309.
2010.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Berman H, Ugarte-Gil MF, Espinosa G,
Tàssies D, Monteagudo J, Reverter JC and Cervera R: Can inherited
thrombophilia modulate the clinical phenotype of patients with
antiphospholipid syndrome? Clin Exp Rheumatol. 31:926–932.
2013.PubMed/NCBI
|
|
35
|
Hotoleanu C: Genetic risk factors in
venous thromboembolism. Adv Exp Med Biol. 906:253–272.
2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Negrini S, Pappalardo F, Murdaca G,
Indiveri F and Puppo F: The antiphospholipid syndrome: From
pathophysiology to treatment. Clin Exp Med. 17:257–267.
2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Islam MA, Khandker SS, Alam F, Kamal MA
and Gan SH: Genetic risk factors in thrombotic primary
antiphospholipid syndrome: A systematic review with bioinformatic
analyses. Autoimmun Rev. 17:226–243. 2018.PubMed/NCBI View Article : Google Scholar
|
